NCT04501861View on ClinicalTrials.gov

Hemodynamic Effect of Norepinephrine Versus Vasopressin on the Pulmonary Circulation in Cardiac Surgery Patients:

PHASE3CompletedINTERVENTIONAL
Enrollment

153

Participants

Timeline

Start Date

November 5, 2020

Primary Completion Date

August 22, 2023

Study Completion Date

December 31, 2024

Conditions
Cardiac Disease
Interventions
DRUG

Vasopressin

Vasopressin (20 IU/100 ml in 5% dextrose) were stored in pre-mixed bags in the operating room, readily available for continuous infusion administration via pre-programed infusion pumps

DRUG

Norepinephrine

Norepinephrine (4 mg/250ml in 5% dextrose) were stored in pre-mixed bags in the operating room, readily available for continuous infusion administration via pre-programed infusion pumps

Trial Locations (1)

44195

Cleveland Clinic, Cleveland

All Listed Sponsors
lead

The Cleveland Clinic

OTHER

NCT04501861 - Hemodynamic Effect of Norepinephrine Versus Vasopressin on the Pulmonary Circulation in Cardiac Surgery Patients: | Biotech Hunter | Biotech Hunter